Abstract
Purpose : To compare the outcome of trabeculectomy for neovascular glaucoma with or without prior in- travitreal injection of bevacizumab. Cases and Method : We reviewed 26 eyes of 24 cases who received trabeculectomy during the past 39 months. Neovascular glaucoma was due to diabetic retinopathy 17 eyes, retinal vein occlusion 6 eyes, and others 3 eyes. Nine eyes received intravitreal bevacizumab one to 14 days before surgery. Results : Final intraocular pressure (IOP) averaged 11.0± 1.4 mmHg in 9 eyes receiving bevacizumb and 9.0± 1.4 mmHg in the other 17 eyes. When final IOP over 15 mmHg or additional treatment glaucoma was defined as death, rate of survival was 77.7% in 9 eyes receiving bevacizumab and 60.0% in the other 17 eyes 12 months after surgery. There was no significant difference between the two groups. Conclusion : Intravitreal injection of bevacizumab may decrease late complications of trabeculectomy and may induce early IOP control.
| Original language | English |
|---|---|
| Pages (from-to) | 1457-1460 |
| Number of pages | 4 |
| Journal | Japanese Journal of Clinical Ophthalmology |
| Volume | 63 |
| Issue number | 9 |
| Publication status | Published - Sep 2009 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
Outcome of trabeculectomy with prior intravitreal bevacizumab injection for neovascular glaucoma. / Kawata, Tetsuhiro; Yamamoto, Naoko; Matsushita, Kyoko; Naito, Tomoko; Ohtsuki, Hiroshi; Takahashi, Makiko.
In: Japanese Journal of Clinical Ophthalmology, Vol. 63, No. 9, 09.2009, p. 1457-1460.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Outcome of trabeculectomy with prior intravitreal bevacizumab injection for neovascular glaucoma
AU - Kawata, Tetsuhiro
AU - Yamamoto, Naoko
AU - Matsushita, Kyoko
AU - Naito, Tomoko
AU - Ohtsuki, Hiroshi
AU - Takahashi, Makiko
PY - 2009/9
Y1 - 2009/9
N2 - Purpose : To compare the outcome of trabeculectomy for neovascular glaucoma with or without prior in- travitreal injection of bevacizumab. Cases and Method : We reviewed 26 eyes of 24 cases who received trabeculectomy during the past 39 months. Neovascular glaucoma was due to diabetic retinopathy 17 eyes, retinal vein occlusion 6 eyes, and others 3 eyes. Nine eyes received intravitreal bevacizumab one to 14 days before surgery. Results : Final intraocular pressure (IOP) averaged 11.0± 1.4 mmHg in 9 eyes receiving bevacizumb and 9.0± 1.4 mmHg in the other 17 eyes. When final IOP over 15 mmHg or additional treatment glaucoma was defined as death, rate of survival was 77.7% in 9 eyes receiving bevacizumab and 60.0% in the other 17 eyes 12 months after surgery. There was no significant difference between the two groups. Conclusion : Intravitreal injection of bevacizumab may decrease late complications of trabeculectomy and may induce early IOP control.
AB - Purpose : To compare the outcome of trabeculectomy for neovascular glaucoma with or without prior in- travitreal injection of bevacizumab. Cases and Method : We reviewed 26 eyes of 24 cases who received trabeculectomy during the past 39 months. Neovascular glaucoma was due to diabetic retinopathy 17 eyes, retinal vein occlusion 6 eyes, and others 3 eyes. Nine eyes received intravitreal bevacizumab one to 14 days before surgery. Results : Final intraocular pressure (IOP) averaged 11.0± 1.4 mmHg in 9 eyes receiving bevacizumb and 9.0± 1.4 mmHg in the other 17 eyes. When final IOP over 15 mmHg or additional treatment glaucoma was defined as death, rate of survival was 77.7% in 9 eyes receiving bevacizumab and 60.0% in the other 17 eyes 12 months after surgery. There was no significant difference between the two groups. Conclusion : Intravitreal injection of bevacizumab may decrease late complications of trabeculectomy and may induce early IOP control.
UR - http://www.scopus.com/inward/record.url?scp=70350337763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350337763&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:70350337763
VL - 63
SP - 1457
EP - 1460
JO - Japanese Journal of Clinical Ophthalmology
JF - Japanese Journal of Clinical Ophthalmology
SN - 0370-5579
IS - 9
ER -